Zobrazeno 1 - 10
of 150
pro vyhledávání: '"D. McSweeney"'
Publikováno v:
Information Processing in Agriculture, Vol 6, Iss 2, Pp 279-284 (2019)
Globally, the Rising Plate Meter (RPM) is a device used to measure compressed sward height, to enable estimation of herbage mass. Despite improved farm management practices aided by a variety of technological advances, the standard design of a RPM ha
Externí odkaz:
https://doaj.org/article/0e6586c868c74206a575f8e619cc583e
Autor:
Morgan D. McSweeney, Sarhad Alnajjar, Alison M. Schaefer, Zach Richardson, Whitney Wolf, Ian Stewart, Pun Sriboonyapirat, Justin McCallen, Ellen Farmer, Bernadette Nzati, Sam Lord, Brian Farrer, Thomas R. Moench, Priya A. Kumar, Harendra Arora, Raymond J. Pickles, Anthony J. Hickey, Mark Ackermann, Samuel K. Lai
Publikováno v:
Advanced Science, Vol 11, Iss 12, Pp n/a-n/a (2024)
Abstract Respiratory syncytial virus (RSV) causes substantial morbidity and mortality in infants, the immunocompromised, and the elderly. RSV infects the airway epithelium via the apical membrane and almost exclusively sheds progeny virions back into
Externí odkaz:
https://doaj.org/article/dd59ff7c17a548cfb3d8d12cd68b18c5
Autor:
Morgan D. McSweeney, Ian Stewart, Zach Richardson, Hyunah Kang, Yoona Park, Cheolmin Kim, Karthik Tiruthani, Whitney Wolf, Alison Schaefer, Priya Kumar, Harendra Aurora, Jeff Hutchins, Jong Moon Cho, Anthony J. Hickey, Soo Young Lee, Samuel K. Lai
Publikováno v:
Bioengineering & Translational Medicine, Vol 8, Iss 1, Pp n/a-n/a (2023)
Abstract The respiratory tract represents the key target for antiviral delivery in early interventions to prevent severe COVID‐19. While neutralizing monoclonal antibodies (mAb) possess considerable efficacy, their current reliance on parenteral do
Externí odkaz:
https://doaj.org/article/690a48d647804603ba7fe97d886a266d
Autor:
Anne M. Talkington, Morgan D. McSweeney, Timothy Wessler, Marielle K. Rath, Zibo Li, Tao Zhang, Hong Yuan, Jonathan E. Frank, M. Gregory Forest, Yanguang Cao, Samuel K. Lai
Publikováno v:
J Control Release
PEGylation is routinely used to extend the systemic circulation of various protein therapeutics and nanomedicines. Nonetheless, mounting evidence is emerging that individuals exposed to select PEGylated therapeutics can develop antibodies specific to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87a16071e342a2ef36c658963c3c29f1
https://doi.org/10.1016/j.jconrel.2022.01.022
https://doi.org/10.1016/j.jconrel.2022.01.022
Autor:
Jonathan E. Frank, Zibo Li, Andrew C. Nyborg, Samuel K. Lai, Hong Yuan, Eric W. Livingston, Morgan D. McSweeney, Tao Zhang, Anne Talkington, Brian LaMoreaux
Publikováno v:
J Control Release
Pegloticase is an enzyme used to reduce serum uric acid levels in patients with chronic, treatment-refractory gout. Clinically, about 40% of patients develop high titers of anti-PEG antibodies (APA) after initial treatment, which in turn quickly elim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcced1b26e453e6e10bdf12b99c5fb2c
https://doi.org/10.1016/j.jconrel.2021.08.051
https://doi.org/10.1016/j.jconrel.2021.08.051
Autor:
Justin K Ma, Terrence D McSweeney, Dayna McManus, Matthew W Davis, Jacob Merwede, David Peaper, Jeffrey E Topal
Publikováno v:
Open Forum Infectious Diseases. 9
Background Rapid microbiology diagnostic results paired with immediate ASP intervention have been shown to decrease time to OAT and improve patient outcomes. For Gram positive (GP) BSI, studies have primarily focused on Staphylococci. However, the va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b7a018a7379d14ccc432527f5134192
https://doi.org/10.1093/ofid/ofac492.273
https://doi.org/10.1093/ofid/ofac492.273
Publikováno v:
Open Forum Infectious Diseases. 9
Background The 2022 IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-negative Infections recommends the use of a novel beta-lactam/beta-lactamase inhibitor, such as ceftolozane-tazobactam (C/T) or ceftazidime-avibactam (C/A), as first-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e71214165476abdc8c08960d99e1085e
https://doi.org/10.1093/ofid/ofac492.1359
https://doi.org/10.1093/ofid/ofac492.1359
Autor:
Kelsie Cowman, Austin Golia, Yi Guo, Terrence D McSweeney, Mei H Chang, Hongkai Bao, Priya Nori
Publikováno v:
Open Forum Infectious Diseases. 9
Background Montefiore Medical Center (MMC), Bronx, NY, established an ambulatory program to offer COVID-19 treatments (monoclonal antibodies [mAB] and oral antivirals) to patients with mild-moderate illness according to emergency use authorization cr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fe166b28202d4135988ddd37004c0e6
https://doi.org/10.1093/ofid/ofac492.1496
https://doi.org/10.1093/ofid/ofac492.1496
Publikováno v:
Radiotherapy and Oncology. 170:S327-S329
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93eae2187a561886beb1a81a37f39868
https://doi.org/10.1016/s0167-8140(22)02357-x
https://doi.org/10.1016/s0167-8140(22)02357-x
Autor:
Thomas R. Moench, Lakshmi Botta, Brian Farrer, Jason D. Lickliter, Hyunah Kang, Yoona Park, Cheolmin Kim, Marshall Hoke, Miles Brennan, Morgan D. McSweeney, Zachary Richardson, John B. Whelan, Jong Moon Cho, Soo Young Lee, Frances Faurot, Jeff Hutchins, Samuel K. Lai
RationaleAlthough COVID-19 is predominantly a respiratory tract infection, current antibody treatments are administered by systemic dosing. We hypothesize that inhaled delivery of a muco-trapping monoclonal antibody would provide a more effective and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f50381f720d81c82120571a038475f2
https://doi.org/10.1101/2022.08.17.22278748
https://doi.org/10.1101/2022.08.17.22278748
